{"disease":{"id":"infliximab","name":"infliximab"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT05813860","title":"HLADQA1*05 Genotype and the Efficacy of Treatment With Infliximab in Chinese Population Crohn's Disease","phase":"PHASE4","overall_status":"NOT_YET_RECRUITING","enrollment_count":976,"lead_sponsor_name":"Sixth Affiliated Hospital, Sun Yat-sen University","has_results":false},{"nct_id":"NCT05043870","title":"Combined Immunosuppression for Pediatric Crohn's Disease","phase":"PHASE4","overall_status":"RECRUITING","enrollment_count":128,"lead_sponsor_name":"Children's Hospital of Fudan University","has_results":false},{"nct_id":"NCT06051253","title":"TDM-based Infliximab Treatment for Active Perianal Fistulizing Crohn's Disease","phase":"PHASE4","overall_status":"RECRUITING","enrollment_count":86,"lead_sponsor_name":"Asan Medical Center","has_results":false},{"nct_id":"NCT04999228","title":"Top Down Versus Step up in Pediatric Ulcerative Colitis","phase":"PHASE4","overall_status":"RECRUITING","enrollment_count":40,"lead_sponsor_name":"Children's Hospital of Fudan University","has_results":false},{"nct_id":"NCT06381518","title":"Switching From Intravenous to Subcutaneous Infliximab in Adult Patients With Inflammatory Bowel Disease","phase":"NA","overall_status":"COMPLETED","enrollment_count":38,"lead_sponsor_name":"Zuyderland Medisch Centrum","has_results":false},{"nct_id":"NCT04530877","title":"Exclusive Enteral Nutrition vs. Infliximab in Chinese CD Patients","phase":"PHASE4","overall_status":"WITHDRAWN","enrollment_count":0,"lead_sponsor_name":"Children's Hospital of Fudan University","has_results":false}],"total":6},"guidelines":[],"source":"Drug Landscape verified database"}